Gagnon Advisors, LLC Exact Sciences Corp Transaction History
Gagnon Advisors, LLC
- $140 Million
- Q3 2024
A detailed history of Gagnon Advisors, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Gagnon Advisors, LLC holds 86,972 shares of EXAS stock, worth $4.72 Million. This represents 4.22% of its overall portfolio holdings.
Number of Shares
86,972
Previous 105,130
17.27%
Holding current value
$4.72 Million
Previous $4.44 Million
33.33%
% of portfolio
4.22%
Previous 3.67%
Shares
2 transactions
Others Institutions Holding EXAS
# of Institutions
671Shares Held
162MCall Options Held
2.58MPut Options Held
2.19M-
Vanguard Group Inc Valley Forge, PA17.8MShares$964 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA15.8MShares$860 Million0.17% of portfolio
-
Wellington Management Group LLP Boston, MA14.3MShares$778 Million0.18% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$655 Million0.01% of portfolio
-
State Street Corp Boston, MA6.68MShares$362 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.6B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...